SmartGene Overview
- Founded
-
1998
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
SmartGene General Information
Description
Developer of bio-informatics application designed to simplify complex data management. The company uses cloud-based modules for multiple applications, including HIV genotyping/resistance, HCV and Influenza analysis, bacterial and fungal identification, microbiome analysis, strain-typing, and molecular epidemiology of viruses and bacteria as well as provides clinical research designed for routine workflows, enabling physicians to follow analytical procedures efficiently.
Contact Information
Website
www.smartgene.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Biotechnology
Medical Records Systems
Primary Office
- EPFL Innovation Park, PSE-C
- 1015 Lausanne
- Switzerland
+41 021 000 00 00
SmartGene Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | Completed | Startup |
SmartGene Patents
SmartGene Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20180046756-A1 | Method and computer system for assessing classification annotations assigned to dna sequences | Inactive | 29-Nov-2007 | ||
| AU-2007361790-B2 | Method and computer system for assessing classification annotations assigned to dna sequences | Active | 29-Nov-2007 | 000000000 | |
| AU-2007361790-A1 | Method and computer system for assessing classification annotations assigned to dna sequences | Active | 29-Nov-2007 | 000000000 | |
| CA-2705216-C | Method and computer system for assessing classification annotations assigned to dna sequences | Active | 29-Nov-2007 | 000000000 | |
| CA-2705216-A1 | Method and computer system for assessing classification annotations assigned to dna sequences | Active | 29-Nov-2007 | G16B50/10 |
SmartGene Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Stefan Emler | Founder, Chief Executive Officer & Director |
SmartGene Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
SmartGene Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| EPFL Innovation Park | Accelerator/Incubator | 000 0000 | 000000 0 |